Genetically modified T cells fight haematological cancer

Pivotal ruxolitinib data shows promise for patients with PV

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL

Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety?

Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows

LHRH analogue goserelin helps preserve fertility among women undergoing chemo for hormone receptor-negative breast cancer

Advances in diagnostic devices in melanoma screening

Investigating anticarcinogenic compounds as an alternative to chemo

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

Comment: Adjuvant ipilimumab in high-risk melanoma